These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1347261)

  • 1. Fulminant peptic ulcer disease in cardiac surgical patients: pathogenesis, prevention, and management.
    Rosen HR; Vlahakes GJ; Rattner DW
    Crit Care Med; 1992 Mar; 20(3):354-9. PubMed ID: 1347261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastroduodenal stress lesions and hemorrhages--pathogenesis, diagnosis, prevention and therapy].
    Gheorghiu T
    Zentralbl Chir; 1995; 120(9):670-6. PubMed ID: 7483866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress ulcers are common after aortic surgery. Endoscopic evaluation of prophylactic therapy.
    Martin LF
    Am Surg; 1994 Mar; 60(3):169-74. PubMed ID: 8116975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid suppression in critically ill patients: what does the evidence support?
    Spirt MJ
    Pharmacotherapy; 2003 Oct; 23(10 Pt 2):87S-93S. PubMed ID: 14587963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of acid suppression in the management and prevention of gastrointestinal hemorrhage associated with gastroduodenal ulcers.
    Sung JJ
    Gastroenterol Clin North Am; 2003 Sep; 32(3 Suppl):S11-23. PubMed ID: 14556432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
    Nash J; Lambert L; Deakin M
    Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing perspective on gastrointestinal complications in patients undergoing cardiac surgery.
    Johnston G; Vitikainen K; Knight R; Annest L; Garcia C
    Am J Surg; 1992 May; 163(5):525-9. PubMed ID: 1575312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug prevention and therapy of acute gastroduodenal lesions (stress ulcers)].
    von Ritter C
    Wien Med Wochenschr; 1992; 142(8-9):180-2. PubMed ID: 1354910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS; McCloskey C; Prasad R; Bezlyak V
    Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
    Aoki T
    J Int Med Res; 1989; 17 Suppl 1():32A-40A. PubMed ID: 2566542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ulcer prevention during anti-rheumatism therapy and in intensive medicine].
    Koelz HR
    Schweiz Rundsch Med Prax; 1994 Jun; 83(25-26):768-71. PubMed ID: 8029591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
    Cook D; Guyatt G; Marshall J; Leasa D; Fuller H; Hall R; Peters S; Rutledge F; Griffith L; McLellan A; Wood G; Kirby A
    N Engl J Med; 1998 Mar; 338(12):791-7. PubMed ID: 9504939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
    Zhou JF; Wan XY; Huang W; Han LL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of ulcerogenic drugs on surgery for the treatment of peptic ulcer disease.
    Bliss DW; Stabile BE
    Arch Surg; 1991 May; 126(5):609-12. PubMed ID: 1673597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute stress ulceration.
    Hillman K
    Anaesth Intensive Care; 1985 Aug; 13(3):230-40. PubMed ID: 2864881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UGI series in renal transplant candidates.
    Lao A; Bach D
    Can Assoc Radiol J; 1988 Sep; 39(3):195-7. PubMed ID: 2901421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.